首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21843篇
  免费   1876篇
  国内免费   1407篇
  25126篇
  2024年   53篇
  2023年   231篇
  2022年   578篇
  2021年   858篇
  2020年   632篇
  2019年   791篇
  2018年   846篇
  2017年   628篇
  2016年   938篇
  2015年   1412篇
  2014年   1634篇
  2013年   1709篇
  2012年   2015篇
  2011年   1928篇
  2010年   1146篇
  2009年   1091篇
  2008年   1255篇
  2007年   1151篇
  2006年   1042篇
  2005年   884篇
  2004年   861篇
  2003年   686篇
  2002年   551篇
  2001年   361篇
  2000年   289篇
  1999年   255篇
  1998年   192篇
  1997年   152篇
  1996年   149篇
  1995年   117篇
  1994年   109篇
  1993年   63篇
  1992年   88篇
  1991年   70篇
  1990年   80篇
  1989年   62篇
  1988年   44篇
  1987年   45篇
  1986年   27篇
  1985年   27篇
  1984年   33篇
  1983年   13篇
  1982年   10篇
  1981年   7篇
  1980年   2篇
  1978年   2篇
  1967年   2篇
  1965年   1篇
  1964年   1篇
  1962年   1篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
酵母表面展示脂肪酶合成己二酸二异辛酯   总被引:2,自引:0,他引:2  
展示酶的酵母细胞既具有固定化酶的优点,又有制备简单、成本较低的特点.采用表面展示南极假丝酵母脂肪酶B (Candida antarctica lipase B,CALB)的毕赤酵母细胞催化合成己二酸二异辛酯(Diisooctyl adipate,DIOA),对该反应体系进行优化,并实现了初步工艺放大制备.经条件优化后,在10mL反应体系中,DIOA的产率可达85.0%.该工艺放大到200mL反应体系时,DIOA产率可达97.8%.经减压蒸馏,DIOA纯度可达到98.2%.该酵母表面展示脂肪酶在合成绿色润滑油己二酸二异辛酯中具有良好应用前景.  相似文献   
92.
Colorectal cancer (CRC) remains a major worldwide cause of cancer-related morbidity and mortality largely due to the insidious onset of the disease. The current clinical procedures utilized for disease diagnosis are invasive, unpleasant, and inconvenient; hence, the need for simple blood tests that could be used for the early detection of CRC. In this work, we have developed methods for glycoproteomics analysis to identify plasma markers with utility to assist in the detection of colorectal cancer (CRC). Following immunodepletion of the most abundant plasma proteins, the plasma N -linked glycoproteins were enriched using lectin affinity chromatography and subsequently further separated by nonporous silica reversed-phase (NPS-RP)-HPLC. Individual RP-HPLC fractions were printed on nitrocellulose coated slides which were then probed with lectins to determine glycan patterns in plasma samples from 9 normal, 5 adenoma, and 6 colorectal cancer patients. Statistical tools, including principal component analysis, hierarchical clustering, and Z-statistics analysis, were employed to identify distinctive glycosylation patterns. Patients diagnosed with colorectal cancer or adenomas were shown to have dramatically higher levels of sialylation and fucosylation as compared to normal controls. Plasma glycoproteins with aberrant glycosylation were identified by nano-LC-MS/MS, while a lectin blotting methodology was used to validate proteins with significantly altered glycosylation as a function of cancer progression. The potential markers identified in this study for diagnosis to distinguish colorectal cancer from adenoma and normal include elevated sialylation and fucosylation in complement C3, histidine-rich glycoprotein, and kininogen-1. These potential markers of colorectal cancer were subsequently validated by lectin blotting in an independent set of plasma samples obtained from 10 CRC patients, 10 patients with adenomas, and 10 normal subjects. These results demonstrate the utility of this strategy for the identification of N -linked glycan patterns as potential markers of CRC in human plasma, and may have the utility to distinguish different disease states.  相似文献   
93.
The protein p53 plays a crucial role in the regulation of cellular responses to diverse stresses. Thus, a major priority in cell biology is to define the mechanisms that regulate p53 activity in response to stresses or maintain it at basal levels under normal conditions. Moreover, further investigation is required to establish whether RNA participates in regulating p53's interaction with other proteins. Here, by conducting systematic experiments, we discovered a p53 interactor—hnRNPC—that directly binds to p53, destabilizes it, and prevents its activation under normal conditions. Upon doxorubicin treatment, the lncRNA SNHG1 is retained in the nucleus through its binding with nucleolin and it competes with p53 for hnRNPC binding, which upregulates p53 levels and promotes p53‐dependent apoptosis by impairing hnRNPC regulation of p53 activity. Our results indicate that a balance between lncRNA SNHG1 and hnRNPC regulates p53 activity and p53‐dependent apoptosis upon doxorubicin treatment, and further indicate that a change in lncRNA subcellular localization under specific circumstances is biologically significant.  相似文献   
94.
Type II collagen is a major protein that maintains biological and mechanical characteristics in articular cartilage. Focal adhesion kinase (FAK) is known to play a central role in integrin signaling of cell–extracellular matrix (ECM) interactions, and chondrocyte–type II collagen interactions are very important for cartilage homeostasis. In this study, we focused on phosphorylation of FAK and MAP kinase in chondrocyte–type II collagen interaction and dedifferentiation, and the effects of FAK knockdown on chondrocyte‐specific gene expression and cell proliferation were determined. The addition of exogenous type II collagen to chondrocytes increased levels of tyrosine phosphorylation, p‐FAKY397, and p‐ERK1/2. In contrast, expression levels of p‐FAKY397 and p‐ERK1/2, but not p‐Smad2/3, were decreased in dedifferentiated chondrocytes with loss of type II collagen expression. Type II collagen expression was significantly increased when dedifferentiated chondrocytes were transferred to alginate beads with TGF‐β1 or type II collagen, but transfected cells with small interfering RNA for FAK (FAK‐siRNA) inhibited mRNA expression of type II collagen and SOX‐6 compared to the control. These FAK‐siRNA‐transfected cells could not recover type II collagen even in the presence of TGF‐β1 or type II collagen in alginate beads culture. We also found that FAK‐siRNA‐transfected cells decreased cell proliferation rate, but there was no effect on glycosaminoglycans (GAGs) secretion. We suggest that FAK is essentially required in chondrocyte communication with type II collagen by regulating type II collagen expression and cell proliferation. J. Cell. Physiol. 218: 623–630, 2009. © 2008 Wiley‐Liss, Inc.  相似文献   
95.
接伟光  李瑾  蔡柏岩 《菌物学报》2014,33(5):1005-1014
研究硫素对不同大豆品种成熟期丛枝菌根(arbuscular mycorrhizal,AM)真菌群落多样性的影响,探索有利于提高3个特定大豆品种根围土壤和根系AM真菌多样性的最佳施硫量,为提高大豆产量和改善大豆品质提供理论依据。试验采用盆栽,选用黑农44(HN44)、黑农48(HN48)、黑农37(HN37)3个大豆品种作为试验材料,设4个硫素处理S1(对照),S2(0.02g/kg),S3(0.04g/kg)和S4(0.06g/kg)。采用PCR-DGGE技术分析3个大豆品种根围土壤和根系中AM真菌群落多样性。结果表明:在S2处理下HN37和HN44根围土壤和根系AM真菌多样性最高,而在S3处理下HN48根围土壤和根系AM真菌多样性最高;DGGE图谱中各样品优势种群变化显著,球囊霉属Glomus和柄囊霉属Funneliformis真菌为3个大豆品种根围土壤和根系中AM真菌的优势菌群。由此可见,硫素对不同大豆品种根围土壤和根系AM真菌群落多样性有显著影响,适量施硫能够提高大豆根围土壤和根系中AM真菌的多样性,不施或过高施硫反而抑制AM真菌的多样性。  相似文献   
96.
放线菌(Actinomycetes)是抗生素等活性天然产物的重要来源,在临床治疗病原菌感染等重大疾病方面发挥着重要作用。由于抗生素滥用等原因导致临床上出现的以耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus, MRSA)等为代表的耐药病菌的种类和数量急剧增加,对人类生存造成了重大威胁。结合现代生物技术进展,加大放线菌来源新抗生素的开发力度刻不容缓。本文对新时期放线菌来源抗生素的发现现状、基于生理操作和基因操作的放线菌来源天然产物挖掘的技术方法等进行综述,以期对放线菌来源活性天然产物的发现提供借鉴。  相似文献   
97.
邵锦  万喆  李若瑜  余进 《菌物学报》2019,38(8):1277-1286
基质辅助激光解析电离飞行时间质谱(matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,MALDI-TOF MS)是近年来新兴的微生物检测技术,通过核糖体蛋白分析实现对真菌快速、准确鉴定。本文针对MALDI-TOF MS用于致病真菌鉴定、分类、体外抗真菌药物敏感性检测以及临床微生物样本直接检测等方面作一综述。  相似文献   
98.
99.
中期因子(Midkine,MK),是一种分泌型肝素结合性生长因子,具有促进细胞有丝分裂、诱导细胞恶化、促进微血管生成、抑制细胞凋亡、促进炎症介质趋化、促纤溶等功能特点;经研究发现,当机体处于健康状态时中期因子除了肾脏及小肠上皮少量表达,其他部位极少表达,但机体出现疾病时,中期因子在体内的表达明显增多,如在多种恶性肿瘤、动脉粥样硬化、各类炎症、糖尿病肾病、高血压及COPD等疾病中均监测到中期因子的高表达,进一步研究发现上述疾病的发生发展与中期因子的功能特点密切相关;近年有学者利用MK在疾病发生发展中的功能特点对疾病进行治疗,特别是MK在肿瘤领域的治疗已成为研究热点,本文结合国内外的最新研究现状就MK与相关疾病的发病机制及治疗作一简要概述,并提出进一步研究的设想。  相似文献   
100.
整合了乙肝表面抗原嵌合基因SS1和SS2的毕赤酵母工程菌株GS115-SS1S2经高密度发酵培养,甲醇诱导,抗原表达量达到300~600mg/L发酵液。SS1S2抗原经细胞破碎、硅胶吸附、疏水层析和凝胶过滤纯化,纯度达99%以上,每升培养物可收获纯化抗原82mg。纯化的SS1S2抗原经Al(OH)3吸附,在NIH小鼠中进行免疫效果评价。三组NIH雌性小鼠,分别腹腔接种2.5μg、0.625μg和0.156μgSS1S2疫苗或商品化的单S疫苗。部分小鼠在30天时采血,测定各疫苗组的ED50值。在SS1S2疫苗组,前S1、前S2和S抗原的ED50值分别为0.46、0.29和0.84μg,而S疫苗组S抗原的ED50为0.99μg。另一部分小鼠分别在7天和14天时采血,考察抗体阳转率与时间的关系。SS1S2疫苗前S1、前S2抗体阳转率在7d和14d时比S抗体的阳转率为高,提示前S抗体出现的时间较早。上述结果显示SS1S2疫苗比单S疫苗具有更好的免疫原性。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号